# EDGAR Filing Document

**Accession Number:** 0001585364
**File Stem:** 0001585364-25-000099
**Filing Date:** 2025-6
**Character Count:** 6995
**Document Hash:** 934f1dbae5fe18896e9b51e2ede66735
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001585364-25-000099.hdr.sgml**: 20250610

**ACCESSION NUMBER**: 0001585364-25-000099

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250606

**FILED AS OF DATE**: 20250610

**DATE AS OF CHANGE**: 20250610

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Khoury Roberto
- **CENTRAL INDEX KEY:** 0002032929

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36353
- **FILM NUMBER:** 251036315

**MAIL ADDRESS:**
- **STREET 1:** C/O PERRIGO COMPANY PLC
- **STREET 2:** 430 MONROE AVE NW
- **CITY:** GRAND RAPIDS
- **STATE:** MI
- **ZIP:** 49503
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PERRIGO Co plc
- **CENTRAL INDEX KEY:** 0001585364
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** THE SHARP BUILDING
- **STREET 2:** HOGAN PLACE
- **CITY:** DUBLIN 2
- **STATE:** L2
- **ZIP:** D02 TY74
- **BUSINESS PHONE:** 269-673-8451

**MAIL ADDRESS:**
- **STREET 1:** 515 EASTERN AVENUE
- **CITY:** ALLEGAN
- **STATE:** MI
- **ZIP:** 49010

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PERRIGO Co Ltd
- **DATE OF NAME CHANGE:** 20130828

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Khoury Roberto<br><sub>(Last) (First) (Middle)</sub><br>C/O PERRIGO COMPANY PLC<br>515 EASTERN AVENUE<br><sub>(Street)</sub><br>ALLEGAN, MI 49010<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-06 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_EVP and President of CSCI_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>PERRIGO Co plc [ PRGO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Ordinary Shares | 2025-06-06 |  | M |  | 7888 | A | $26.16 | 7888 | D |  |
| Ordinary Shares | 2025-06-06 |  | F |  | 4110 | D | $26.16 | 3778 | D |  |
| Ordinary Shares | 2025-06-06 |  | M |  | 2980 | A | $26.16 | 6758 | D |  |
| Ordinary Shares | 2025-06-06 |  | F |  | 1553 | D | $26.16 | 5205 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(1)</sup> | 2025-06-06 |  | A |  | 21101 |  | <sup>(2)</sup> | <sup>(2)</sup> | Ordinary Shares | 21101 | <sup>(1)</sup> | 21101 | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2025-06-06 |  | M |  |  | 7888 | <sup>(3)</sup> | <sup>(3)</sup> | Ordinary Shares | 7888 | <sup>(1)</sup> | 7888 | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2025-06-06 |  | M |  |  | 2980 | <sup>(4)</sup> | <sup>(4)</sup> | Ordinary Shares | 2980 | <sup>(1)</sup> | 5959 | D |  |

---

### Footnotes:

(1) Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

(2) Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 June 2026.

(3) Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 2 equal annual installments beginning 7 June 2025.

(4) Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 June 2025.

**Signature:** s/ Victor Torres, attorney-in-fact for Mr. Roberto Khoury  
**Date:** 2025-06-10

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**